Lilly to acquire sleep drug biotech firm Centessa in $6.3 billion deal
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
Launches advanced bone density systems in India & Dubai
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
Subscribe To Our Newsletter & Stay Updated